Blog

Driven by rollout of the next-generation Wattbike AIR-PRO across Germany’s Fitness First’s premium Black Label facilities

Major order follows April’s $1M+ order from Woodway for the US market

AUSTIN, TEXAS / ACCESS Newswire / December 11, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, and FORME brands, and pending acquirer of Sportstech, today announced a major new Wattbike order placed by one of Germany’s largest and fastest-growing fitness operators.

The order for 85 next-generation Wattbike AIR-PRO units, valued at more than $200K, is designated primarily for Fitness First’s Black Label (premium-tier) facilities. Deliveries are expected to begin in late Q1 2026, with most sites receiving two units each. The order represents a repeat purchase commitment from a longstanding Wattbike customer.

Fitness First operates under the LifeFit Group, a rapidly expanding German fitness and wellbeing platform that has grown from roughly 100 to nearly 220 locations in recent years through acquisitions. A system-wide rebranding is underway to consolidate multiple acquired chains under the Fitness First name, with expansion plans that could bring the network to as many as 300 sites.

The new AIR-PRO units will be supplied through Woodway GmbH, the longstanding distributor for both TRNR and Wattbike. Woodway has cultivated deep commercial relationships across Germany and has helped establish both TRNR and Wattbike as recognized platforms for delivering performance-training solutions for gym operators seeking accurate, durable, and data-driven equipment for athletic training environments.

Trent Ward, Co-Founder and CEO of TRNR, said: “This order reflects the continued momentum we are seeing across the Wattbike brand and reinforces its position as the global standard in performance cycling. Fitness First’s growing footprint – and its decision to adopt the new AIR-PRO across its premium Black Label sites – demonstrates the enduring value of Wattbike’s engineering precision, product reliability, and training intelligence. We are also pleased that our long-standing partner Woodway continues to play a central role in expanding Wattbike’s presence across Europe after placing an order for more than $1M in April for the US market. Orders like this highlight the strategic importance of our acquisitions and the opportunities ahead as we scale our portfolio globally.”

For more commentary, information and details of TRNR’s strategy, as well as to sign up for direct updates, see the Company’s investor website, latest FAQs and required filings with the US Securities & Exchange Commission (SEC).

TRNR Investor Contact
ir@interactivestrength.com

About Interactive Strength Inc.:

Interactive Strength Inc. (NASDAQ:TRNR) has established a leading portfolio of premium fitness brands-Wattbike, CLMBR, and FORME-that combine advanced hardware, smart technology, and immersive content to deliver exceptional training experiences for both commercial and home use.

Wattbike offers a range of high-performance indoor bikes that set the global standard in cycling. Known for unmatched accuracy, realistic ride feel, and advanced performance tracking, Wattbike is trusted by elite athletes, national teams, and fitness enthusiasts around the world.

CLMBR redefines the next-generation vertical climbing experience through its patented open-frame design and immersive touchscreen, delivering a high-intensity, low-impact workout that is both efficient and effective.

FORME delivers strength, mobility, and recovery training through immersive content, performance-grade hardware, and expert coaching. Its wall-mounted systems include the Studio, a smart fitness mirror for guided programming and live 1:1 personal training, and the Lift, which adds smart resistance cable training-ideal for high-performance environments and sport-specific development.

From elite performance to everyday wellness, TRNR’s ecosystem of performance-focused solutions delivers data-driven outcomes for athletes, fitness enthusiasts, and commercial operators.

Forward Looking Statements:
This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements generally are accompanied by words such as “believe”, “project”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the possibility and repeatability of sales commitments by TRNR or its subsidiary brands, and whether orders will eventually be fulfilled and generate revenue. The reader is cautioned not to rely on these forward-looking statements, and these statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. Risks and uncertainties include but are not limited to: demand for our products and for Wattbike’s products (collectively, the “Products”); competition, including technological advances made by and new products released by our and our competitors; our ability to accurately forecast consumer and/or fitness facility or other demand for our Products and adequately maintain inventory of our Products; and our reliance on a limited number of suppliers and distributors for our Products. A further list and descriptions of these risks, uncertainties and other factors can be found in filings with the Securities and Exchange Commission. To the extent permitted under applicable law, the Company assumes no obligation to update any forward-looking statements.

# # #

SOURCE: Interactive Strength Inc.

View the original press release on ACCESS Newswire

NEW YORK, NY / ACCESS Newswire / December 11, 2025 / Black Titan Corporation (NASDAQ:BTTC) today announced the planned introduction of Digital Asset Treasury Plus (DAT+), a comprehensive strategic framework outlining how the Company may evaluate and potentially engage with digital assets going forward. DAT+ is structured as a multi-layered approach that considers utility, governance, liquidity, operational readiness, earnings alignment, and strategic collaboration.

To provide clarity for shareholders and market participants, Black Titan will release a series of press announcements throughout the day, with each highlighting one of the core pillars of the DAT+ strategy. The Company is commencing this series with the release of Pillar 1: Active Utility Deployment & Cash Flow Potential.

“Digital assets are no longer a single-dimensional asset class,” said Czhang Lin, Co-Chief Executive Officer of Black Titan. “DAT+ reflects our intention to evaluate digital assets through a holistic lens – from risk management and utility to liquidity, revenue alignment, and strategic collaboration. Each component is significant, and this series allows us to explain the framework in a clear and structured way.”

Pillar 1: Active Utility Deployment & Cash Flow Potential

As the first pillar of the DAT+ strategy, Black Titan introduces a utility-first framework that prioritizes real ecosystem participation and operational relevance when evaluating digital assets.

Under this approach, digital assets must demonstrate practical, functional roles within their native ecosystems, including:

• enabling access to network services,

• participating in fee-based protocol activity,

• supporting on-chain operations such as staking or validation, and

• serving as a requirement for specialized product usage.

This utility-driven evaluation reflects a shift away from passive models historically associated with corporate digital asset holdings, emphasizing instead productive participation aligned with real economic activity.

“Utility is the anchor of the DAT+ framework,” added Czhang Lin. “We believe digital assets are most valuable when they support real economic functions, and this first pillar defines how we assess that utility in a measurable and operationally relevant way.”

Upcoming Releases in the DAT+ Series

Following today’s announcement of Pillar 1, Black Titan will release additional pillars covering:

• Risk Management & Diversified Allocation Principles

• Token Utility Integration & Corporate Earnings Alignment

• Strategic Co-Support & Ecosystem Partnerships

• Liquidity Standards & Operational Readiness Requirements

Each pillar will provide further detail on how DAT+ may guide future evaluation of digital assets through a balanced, institutional, and innovation-focused approach.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect Black Titan’s current expectations regarding strategic initiatives and growth plans. Forward-looking statements are subject to numerous risks and uncertainties that may cause actual results to differ materially from those expressed or implied, including market volatility, regulatory developments, and other factors described in Black Titan’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.

Media & Investor Contact

Czhang Lin
Co-Chief Executive Officer
contact-us@blacktitancorp.com

SOURCE: Black Titan Corp

View the original press release on ACCESS Newswire

Company Commits Revenue from Majority Interest in BONK.fun to Fuel Strategic Target of Owning 5% of Global Supply; Beverage Division to Reinvest for Growth

SCOTTSDALE, AZ / ACCESS Newswire / December 11, 2025 / Following the effective date of its strategic reverse stock split, Bonk, Inc. (NASDAQ:BNKK) today reaffirmed its primary capital allocation policy: the Company intends to deploy net cash flow generated from its digital asset operations directly into the accumulation of BONK digital assets.

This directive creates a direct mechanical link between the Company’s digital ecosystem growth and its treasury strategy. As the Company executes its business plan and realizes revenue from its 51% majority interest in BONK.fun, available capital from that division will be systematically directed toward the open-market purchase of BONK assets to reach the Company’s stated target of holding 5% of the total circulating supply.

The “Revenue-to-Asset” Pipeline Bonk, Inc. has engineered a unique corporate structure designed to act as a continuous accumulation engine while supporting operational sustainability. The capital allocation strategy prioritizes treasury growth from digital sources while allowing traditional operations to self-fund.

• Digital Asset Operations (Treasury Engine): Revenue generated from the Company’s controlling interest in BONK.fun-a platform with an implied asset value of ~$30 million-will be reinvested into the ecosystem’s underlying asset.

• Traditional Business Operations (Growth Engine): Revenue from the Yerbaé beverage brand will be reinvested directly into the beverage division to support marketing, inventory, and expansion efforts.

Strategic Rationale The Company views the BONK digital asset not merely as a speculative holding, but as the fundamental unit of account for a growing digital economy. By aggressively converting digital operational cash flow into treasury assets, Bonk, Inc. aims to:

1. Compound Value: Leverage dollar-cost averaging to build a massive position.

2. Reduce Supply: Remove assets from circulation, contributing to scarcity.

3. Maximize NAV: Drive long-term expansion of the Company’s Net Asset Value per share.

Leadership Commentary “We are not building a company that just sits on cash; we are building a vault,” said Mitchell Rudy (a.k.a. Nom), Board Director and Core Contributor. “Our shareholders deserve to know exactly where our focus lies. Every dollar of net profit generated by BONK.fun is a potential soldier in our campaign to secure 5% of the BONK supply. We have cleared our primary debts and streamlined our stock structure so that nothing stands in the way of this accumulation strategy. When BONK.fun wins, our treasury grows. It is that simple.”

Jarrett Boon, CEO of Bonk, Inc., added, “The reverse stock split was the final structural step to prepare us for this phase. We now have the right share count, the right institutional mandate, and the right revenue engines. Our mandate for 2026 is execution: turning digital operational success into tangible treasury growth while ensuring our beverage division has the resources to scale independently. We believe this is the most effective way to drive asymmetric returns for our equity holders.”

About Bonk, Inc. Bonk, Inc. (NASDAQ:BNKK) is a company evolving to bridge the gap between traditional public markets and the digital asset ecosystem. Through its subsidiary BONK Holdings LLC, the Company executes a strategy focused on acquiring revenue-generating assets within the decentralized finance space. The Company also operates a growing beverage division holding the patented Sure Shot and Yerbaé brands.

Investor Relations Contact: Phone: 888.257.8061 Email: investors@bonkdat.com

Forward-Looking Statements: This press release contains forward-looking statements regarding the Company’s capital allocation strategy, projected revenue, and treasury accumulation goals. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially due to factors such as market volatility in the digital asset sector, consumer demand for beverage products, the performance of the BONK.fun platform, and other risks detailed in Bonk, Inc.’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update forward-looking statements.

SOURCE: Bonk, Inc.

View the original press release on ACCESS Newswire

Engineered to Protect Vision Indoors and Out – Beyond UV Protection

GLENS FALLS, NEW YORK / ACCESS Newswire / December 11, 2025 / Solir Optics, an emerging leader in protective eyewear innovation, today announced the launch of its debut collection engineered to safeguard eyes from harmful invisible light – both outside and under high-intensity indoor lighting. Built to go beyond traditional ultraviolet (UV) protection, Solir Optics introduces a patent-pending combination of infrared (IR) defense, UV415 protection, blue-light filtration, and advanced visible-light control to deliver enhanced contrast, lasting comfort, and comprehensive protection in demanding light environments.

Infrared radiation is invisible, heat-carrying wavelengths of light that our eyes absorb every day – outdoors, where it accounts for nearly half of the sun’s energy, and indoors, where high-intensity artificial lighting can expose users to concentrated IR. Prolonged exposure can subtly warm internal eye tissues, contributing to discomfort, fatigue, and long-term concerns including accelerated lens aging and cataract risk. Traditional sunglasses stop at UV protection. Solir Optics addresses this hidden risk with new lens technology designed to block more than 90% of infrared between 780nm and 2000nm, reducing thermal stress for sustained eye health.

Beyond invisible-light protection, Solir Optics’ infrared filtration also helps shield personal privacy by disrupting biometric scanning – an emerging concern in an increasingly sensor-driven world. By obscuring eye and facial data from IR-based cameras, Solir Optics eyewear offers an added layer of privacy protection from unwanted digital surveillance both indoors and outdoors.

“Solir Optics merges advanced science with thoughtful design so people can work, explore, and perform with protected vision,” said Scott MacGuffie, founder and president of Solir Optics. “Our mission is to safeguard and empower vision in a world where most of the risks to our eyesight can’t be seen. With Solir Optics, people can move through bright, demanding conditions with greater confidence and comfort.”

The debut collection, starting at $70, features five active-lifestyle frame styles paired with five vibrant lens options, including mirrored and photochromic choices. Solir Optics frames are crafted from ultradurable, bio-based injection-molded nylon with flexible temples and non-slip nose pads for a secure, comfortable fit. Select styles include integrated venting to prevent fogging, and two models meet ANSI Z87+ impact-resistance standards for eye protection in demanding work environments. Each pair ships with a protective microfiber pouch made from recycled materials to keep lenses clean and scratch-free.

The Solir Optics collection is available now at www.soliroptics.com.

About Solir Optics

Solir Optics is redefining protective eyewear with advanced infrared-blocking performance lenses built to guard eyes from invisible threats. Going beyond UV protection, the company’s patent-pending lens technology manages the full spectrum of harmful light-UV, blue, and IR-while enhancing color and contrast to deliver vibrant vision, reduce thermal stress, and provide lasting comfort in high-intensity environments. With sustainably built, impact-resistant frames and lenses designed for movement and all-day wear, Solir Optics creates eyewear that protects people at work and at play.

View the original press release on ACCESS Newswire

Milestone Advances U.S. and Secures Location for Flagship Texas Facility Supporting Domestic Critical-Minerals Supply Chains

VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec” or the “Company”) is pleased to note today’s press release by HyProMag USA, LLC (“HyProMag USA”), its U.S.-based joint venture rare earth permanent magnet recycling and manufacturing company.

HyProMag USA announced it has finalized the lease agreement for its proposed rare-earth magnet recycling and manufacturing facility in Dallas-Fort Worth, Texas.

Julian Treger, Chief Executive of CoTec commented: “Finalizing the Texas Facility lease represents another major milestone in HyProMag USA’s mission to deliver a secure, sustainable rare-earth magnet supply chain in the United States. With the site secured and local partnerships in place, we’re moving decisively toward completing financing, construction and the first commercial-scale production of recycled magnets in the United States.”

HyProMag USA’s first facility (the “Texas Facility” or the “Project”) will be located at Ironhead Commerce Center, Building 1, Dallas-Fort Worth, Denton County, Texas. The Project site is strategically located next to critical infrastructure, the BNSF intermodal rail link and the Alliance airport. The milestone marks the next phase in HyProMag USA’s Project expansion and underscores its commitment to building a fully domestic, circular supply chain for rare-earth magnets critical to revitalizing U.S. industry and to provide a long-term domestic supply of critical minerals.

The Texas Facility will leverage the patented Hydrogen Processing of Magnet Scrap (“HPMS”) technology – developed by the Magnetic Materials Group at the University of Birmingham with over 25 years of R&D and exclusively licensed to HyProMag Limited, a 50% partner in HyProMag USA, to recover and remanufacture rare earth magnets from end-of-life products. HyProMag USA targets commissioning the Texas Facility by mid-2027, subject to final permitting and financing, and anticipates creating approximately 90 to 100 skilled jobs in magnet manufacturing, engineering and advanced materials processing. HyProMag USA has collaborated closely with the Town of Northlake to advance the Texas Facility. Additionally, HyProMag USA has also established and expanded its feedstock-supply partnership with Intelligent Lifecycle Solutions (ILS), a global electronics recycling company, which has commenced stockpiling magnet-bearing materials to support commissioning of HyProMag’s U.S. operations.

HyProMag USA will occupy 50 percent of Building 1 at Ironhead Commerce Center, approximately 128,000 square feet. The Texas Facility will serve as the central hub of HyProMag USA’s hub-and-spoke short-loop network, which includes planned pre-processing facilities in Nevada and South Carolina. The Project’s modular design allows for faster replication across the U.S., providing a more scalable blueprint for restoring rare-earth magnet production and reducing reliance on overseas sources.

For further information, please refer to HyProMag USA’s press release, available at: www.hypromagusa.com

A fly over of the facility’s location can be found here: https://www.youtube.com/watch?v=J8RHkZSfo0Y

About HyProMag USA

HyProMag USA, LLC is owned 50:50 by CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) and HyProMag Limited. HyProMag Limited is 100% owned by Maginito Limited which is owned on a 79.4%/20.6% basis by Mkango Resources Ltd. (AIM/TSX-V: MKA) and CoTec.

For more information, please visit www.hypromagusa.com

HyProMag USA Feasibility Study

The independent Feasibility Study on the development of a state-of-the-art rare earth magnet recycling and manufacturing operation in the United States includes the Texas Facility, and two pre-processing facilities located in South Carolina and Nevada respectivelyⁱ . In March 2025, HyProMag USA announced the expansion of the detailed engineering phase to include three HPMS vesselsⁱⁱ and that it was initiating concept studies for further expansion and complementary “Long Loop” recyclingⁱⁱⁱ . The Texas Facility’s annual production is expected to be 750 metric tons per annum of recycled sintered NdFeB magnets and 807 metric tons per annum of associated NdFeB co-products (total payable capacity – 1,557 metric tons NdFeB within five years of commissioning) over a 40-year operating life. It is expected the Texas Facility will provide significant optionality to supply the U.S. market with additional NdFeB alloy powder while assisting in revitalizing the U.S. magnet sector with the creation of 90-100 skilled magnet manufacturing jobs.

In March 2025, HyProMag USA announced the results of an independent ISO-Compliant product carbon footprint study which confirmed an exceptionally low CO₂ footprint of 2.35 kg CO₂ eq. per kg of NdFeB cut sintered block product^iv .

In August 2025, HyProMag USA announced ILS had formally commenced its stockpiling of feedstock initiative pursuant to the recently announced feedstock supply and pre-processing site share agreement between HyProMag USA and ILS.

In September 2025, HyProMag USA announced the commissioning of a concept study to evaluate the expansion of its operations into Nevada and South Carolina in collaboration with ILS^v and the commissioning of a concept study to evaluate long-loop recycling with Worley Group Inc^vi .

About CoTec

CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) is redefining the future of resource extraction and recycling. Focused on rare earth magnets and strategic materials, CoTec integrates breakthrough technologies with strategic assets to unlock secure, sustainable, and low-cost supply chains for the United States and its allies.

CoTec’s mission is clear: accelerate the energy transition while strengthening U.S. economic and national security. By investing in and deploying disruptive technologies, the Company delivers capital-efficient, scalable solutions that transform marginal assets, tailings, waste streams, and recycled products into high-value critical minerals.

From its HyProMag USA magnet recycling joint venture in Texas, to iron tailings reprocessing in Québec, to next-generation copper and iron solutions backed by global majors, CoTec is building a diversified portfolio with long-term growth, rapid cash flow potential, and high barriers to entry. The result is a game-changing platform at the intersection of technology, sustainability, and strategic materials.

For more information, please visit www.cotec.ca

For further information, please contact:

Braam Jonker – (604) 992-5600

Forward-Looking Information Cautionary Statement

Statements in this press release regarding the Company and its investments which are not historical facts are “forward-looking statements” which involve risks and uncertainties, including statements relating to the Texas Facility, Feasibility Study, potential future employment and production, the entering of the lease agreement for the Texas Facility and management’s expectations with respect to its current and potential future investments, including HyProMag USA, and the benefits to the Company which may be implied from such statements. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results in each case could differ materially from those currently anticipated in such statements, due to known and unknown risks and uncertainties affecting the Company, including but not limited to resource and reserve risks; environmental risks and costs; labor costs and shortages; uncertain supply and price fluctuations in materials; increases in energy costs; labor disputes and work stoppages; leasing costs and the availability of equipment; heavy equipment demand and availability; contractor and subcontractor performance issues; worksite safety issues; project delays and cost overruns; extreme weather conditions; and social and transport disruptions. For further details regarding risks and uncertainties facing the Company please refer to “Risk Factors” in the Company’s filing statement dated April 6, 2022, a copy of which may be found under the Company’s SEDAR profile at www.sedar.com. The Company assumes no responsibility to update forward-looking statements in this press release except as required by law. Readers should not place undue reliance on the forward-looking statements and information contained in this news release and are encouraged to read the Company’s continuous disclosure documents which are available on SEDAR at www.sedarplus.ca .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

ⁱ https://www.cotec.ca/news/hypromag-usa-feasibility-study-demonstrates-robust-economics-and-the-opportunity-to-develop-a-major-new-domestic-source-of-recycled-rare-earths-magnets-for-the-united-states

ⁱⁱ https://cotec.ca/news/hypromag-usa-expands-detailed-engineering-phase-to-include-three-hpms-vessels-and-initiates-concept-studies-for-further-expansion-and-complementary-long-loop-recycling

ⁱⁱⁱ Conventional leach, extraction purification and precipitation process

^iv https://cotec.ca/news/hypromag-usas-iso-compliant-product-carbon-footprint-study-confirms-exceptionally-low-co2-footprint-of-235-kg-co2-eq-per-kg-of-ndfeb-cut-sintered-block

^v https://hypromagusa.com/hypromag-usa-to-commission-scoping-study-to-triple-capacity/

^vi https://hypromagusa.com/hypromag-usa-project-update-for-its-rare earth-magnet-recycling-and-manufacturing-plants-in-the-united-states/

SOURCE: CoTec Holdings Corp.

View the original press release on ACCESS Newswire

Meeting scheduled to reconvene December 19, 2025, at 1:00 p.m. ET

ORLANDO, FLORIDA / ACCESS Newswire / December 4, 2025 / Unusual Machines, Inc. (NYSE American:UMAC), a leading provider of NDAA-compliant drone components, today announced that its Annual Meeting of Stockholders, which convened on December 1, 2025, has been adjourned until December 19, 2025, at 1:00 p.m. ET. to solicit additional proxies to achieve a quorum and for its proposal to approve the election of five directors for a one-year term expiring at the next Annual Meeting of Stockholders. The adjourned meeting will be a completely “virtual” meeting of the stockholders, and stockholders will be able to listen and participate in the virtual meeting as well as vote during the live webcast of the meeting by visiting www.virtualshareholdermeeting.com/UMAC2025 and entering the control ID and Request ID number printed on the form of proxy or voting instruction form.

The Board of Directors believes approval of the proposal is in the best interests of Unusual Machines, Inc. and its stockholders. The proposal is described in more detail in Unusual Machines, Inc.’s proxy statement dated October 20, 2025, furnished to stockholders in connection with the Annual Meeting filed under the Company’s EDGAR profiles. It can also be found on the Company’s website at https://www.unusualmachines.com/financials/sec-filings/#

At the time of the meeting, there was no quorum, and insufficient votes were cast to approve the proposal. Unusual Machines encourages any stockholder who has not yet voted their shares on the proposal or is uncertain whether their shares have been voted on the proposal to contact their broker or bank. The record date of the meeting shall remain October 6, 2025. Accordingly, the Board of Directors and management request that stockholders as of the record date, October 6, 2025, please vote their proxies as soon as possible, but no later than December 18, 2025, at 11:59 p.m. (Eastern Time). Stockholders who have previously submitted their proxy or otherwise voted for the proposal and who do not want to change their vote need not take any action.

How do I vote?

If you are a stockholder of record, you may vote*:

1. By Internet. The website address for Internet voting is on your proxy card.

2. By phone. Call 1-800-690-6903 and follow the instructions on your proxy card.

3. By mail. Mark, date, sign, and mail promptly the enclosed proxy card (a postage-paid envelope is provided for mailing in the United States).

4. In person: You may vote in person by attending the virtual Annual Meeting.

* If you vote by Internet or phone, please DO NOT mail your proxy card.

If your shares are held in street name, you may vote:

1. By Internet. The website address for Internet voting is on your voting instruction form provided by your bank, broker, or similar organization.

2. By mail. Mark, date, sign, and mail promptly the enclosed voting instruction form provided by your bank or broker.

3. In person: You may vote in person by attending the virtual Annual Meeting.

If you are a beneficial owner, you must follow the voting procedures of your nominee included with your proxy materials. If your shares are held by a nominee and you intend to vote at the Annual Meeting, please be prepared to demonstrate proof of your beneficial ownership as of the record date (such as your most recent account statement as of the record date, a copy of the voting instruction form provided by your broker, bank, trustee or nominee, or other similar evidence of ownership) and a legal proxy from your nominee authorizing you to vote your shares.

What constitutes a Quorum?

To carry on the business of the Annual Meeting, we must have a quorum. A quorum is present when one-third of the voting power of the outstanding shares of all classes or series of stock entitled to vote, as of the record date, are represented in person or by proxy. Shares owned by Unusual Machines are not considered outstanding or present at the Annual Meeting. Broker non-votes (because there are routine matters presented at this Annual Meeting) and abstentions are counted as present for the purpose of determining the existence of a quorum.

Stockholder Questions

If you have any questions or require any assistance in voting your shares, please call Innisfree M&A Incorporated at 877-800-5186.

About Unusual Machines

Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to Fact.MR, the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032. For more information, please visit www.unusualmachines.com.

Investor Contact:

CS Investor Relations
investors@unusualmachines.com

SOURCE: Unusual Machines, Inc.

View the original press release on ACCESS Newswire

ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provides a business update for the quarter ended September 30, 2025.

Q3 2025 and Recent Highlights

• Expanded its scientific team with the addition of Mark J. Jaroszeski, PhD, a tenured professor in the Department of Medical Engineering at the University of South Florida. Dr. Jaroszeski, who holds a PhD in Engineering Science with a dissertation focused on mechanically facilitated cell-cell electrofusion. His expertise is expected to assist in further developing Aspire’s unique sublingual delivery technology.

• Submitted its Pre-IND meeting request and briefing package to the U.S. Food and Drug Administration (FDA). The submission concerns the Company’s lead product candidate, a fast-acting, high-dose sublingual aspirin formulation for the treatment of suspected acute myocardial infarction (AMI) and represents a significant milestone on the path to potential FDA approval. On November 13, 2025, the FDA responded positively to the request and stated it would provide written responses in lieu of a meeting no later than January 2, 2026.

• Participated in the CPHI Frankfurt trade show, the world’s largest pharmaceutical event. The Company engaged in numerous strategic discussions with global pharmaceutical companies regarding technical collaboration and licensing opportunities for its lead product candidate, a novel sublingual high-dose aspirin. The conference has led to several licensing opportunities that the Company is considering.

• Filed an omnibus patent application with the U.S. Patent and Trademark Office for its sublingual delivery technology. This application – which seeks patent protection of Aspire’s proprietary technology in a variety of classes of drugs and other substances–focuses exclusively on protecting the Company’s advanced sublingual drug delivery system, which is designed to enhance the pharmacokinetic performance of Active Pharmaceutical Ingredients (“APIs”) and other substances into the bloodstream, increasing bioavailability and improving speed of onset. The omnibus patent supplements the patent protections already provided by Aspire’s previously filed patents.

• Shared its pipeline progress and key milestones expected through the remainder of 2025 and early 2026. The company is focusing its pipeline on reformulating approved drugs for multi-billion-dollar markets by utilizing its disruptive, patent-pending sublingual delivery technology and anticipates filing as many as five to ten additional patents before the end of Q1 2026.

• Began its influencer marketing campaign designed to drive conversion, brand awareness and loyalty for its innovative BUZZ BOMB™ caffeine product. Featuring 50mg of caffeine and offered in four flavors (Tropical Fruit, Mixed Berry, Peach Mango, and Coffee Mocha), BUZZ BOMB™ provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken as needed for immediate effect.

• Increased the production capacity of its BUZZ BOMB™ single dose caffeine supplement through a new manufacturing relationship with SupraNaturals, a well-established contract manufacturer of nutritional and dietary supplements. As part of this agreement, Aspire Biopharma announced an initial production order of two million servings (100,000 20-packs) of BUZZ BOMB™ caffeine supplement, marking a significant milestone in the Company’s expansion efforts. The new product will be available for sale just before Christmas.

• Published positive final data from its randomized, crossover bioavailability trial to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of Aspire’s investigational new sublingual aspirin product compared to chewed uncoated aspirin tablets in healthy adults. The sublingual formulation begins to inhibit platelet aggregation in under two minutes, acting approximately four to five times as fast as chewed aspirin.

• Announced the successful launch and distribution of over 30,000 BUZZ BOMB™ sample four-packs, its new sublingual caffeine supplement, at FitCon and FitExpo, held August 1-3, in Salt Lake City and Anaheim, with an estimated combined attendance in excess of 70,000 people.

• Announced that the Company’s Board of Directors (Board) has appointed Kraig Higginson as interim Chief Executive Officer (CEO), effective July 24, 2025. Mr. Higginson serves as Chairman of the Board and previously served as CEO of Aspire for nearly four years.

• Buzz Bomb Caffeine Company LC, a wholly owned subsidiary of Aspire:

  • Unveiled its new e-commerce solution, buzzbombcaffeine.com with BUZZ BOMB™ as its featured launch product. This new seamless direct-to-consumer shopping experience allows consumers to order BUZZ BOMB™ on the Buzz Bomb platform and have them shipped directly to their door with access to exclusive promotions, and customer support. To celebrate the launch, customers who register for Buzz Bomb’s e-commerce site will have first access to special pricing, free shipping offers, and other promotions. The site features an introductory sample pack of four flavors as well as 30-packs in various flavors.

  • Announced positive initial consumer feedback from the Company’s sampling of its sublingual caffeine supplement, BUZZ BOMB™. featuring 50mg of caffeine and designed to support sustained energy and mental focus, BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar caffeine market to help athletes, fitness enthusiasts, and others wanting a lift to maximize their performance potential. Buzz Bomb™ provides nearly instant energy, in easy-to-use convenient packs, which can be taken easily and without the need for mixing with water or relying on unhealthy energy drinks or soda.

Anticipated Upcoming Milestones

• Sublingual High-dose Aspirin (Lead Program)

  • H1 2026: Target submission of New Drug Application (NDA).

• Sublingual ED medication

  • H1 2026: Finalize formulation and manufacture test product.

  • Mid-2026: Initiate Phase 1 pharmacokinetic (PK) clinical cross-over study.

Kraig Higginson, Interim CEO of Aspire Biopharma, commented:

“Our third-quarter results represent the blueprint for our future value creation. We have clinically proven the superiority of our technology with sublingual aspirin, de-risking the platform, and we have demonstrated our ability to execute commercially with Buzz Bomb Caffeine Company’s successful launch of BUZZ BOMB™.”

Higginson continued, “Looking ahead, investors can see a clear line of sight to a series of major, value-driving catalysts. The most significant is our targeted NDA submission for sublingual aspirin in the first half of 2026, which aims to disrupt a multi-billion-dollar market. This will be followed by the initiation of clinical studies for our sublingual ED and other programs, our entry points into some of the largest pharmaceutical markets in the world. Our ability to scale commercially is already being validated, as demonstrated by Buzz Bomb Caffeine Company’s second production order of two million servings of BUZZ BOMB™ to meet growing demand. We believe the accomplishments of this quarter have set the stage for a transformative period of growth, and the market has yet to fully recognize the value of the catalysts that lie directly ahead.”

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma has developed a patent-pending sublingual delivery technology that can deliver drugs to the body rapidly and precisely. This technology offers the potential to improve effectiveness and reduce side effects by going directly to the bloodstream and avoiding the gastrointestinal tract. Aspire Biopharma’s delivery technology can be applied to many different active pharmaceutical ingredients (APIs) and other bioactive substances, spanning both small and large molecule therapeutics, nutraceuticals and supplements.

For more information, please visit www.aspirebiolabs.com

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the “safe harbor” provisions created by those laws. Aspire’s forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding our future operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements represent our views as of the date of this press release and involve a number of judgments, risks and uncertainties. We anticipate that subsequent events and developments will cause our views to change. We undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include general market conditions, whether clinical trials demonstrate the efficacy and safety of our drug candidates to the satisfaction of regulatory authorities, or do not otherwise produce positive results which may cause us to incur additional costs or experience delays in completing, or ultimately be unable to complete the development and commercialization of our drug candidates; the clinical results for our drug candidates, which may not support further development or marketing approval; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials and marketing approval; our ability to achieve commercial success for our drug candidates, if approved; our limited operating history and our ability to obtain additional funding for operations and to complete the development and commercialization of our drug candidates; and other risks and uncertainties set forth in “Risk Factors” in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and you are cautioned not to rely unduly upon these statements. All information in this press release is as of the date of this press release. The information contained in any website referenced herein is not, and shall not be deemed to be, part of or incorporated into this press release.

Aspire Biopharma Holdings, Inc.

Contact

Brett Maas
Hayden IR: (646) 536-7331
brett@haydenir.com

James Carbonara
Hayden IR: (646)-755-7412
james@haydenir.com

SOURCE: Aspire Biopharma Holdings, Inc.

View the original press release on ACCESS Newswire